Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03152279 · ClinicalTrials.gov registry record
Assessment of Duodenal Epithelial Integrity in Celiac Disease With Mucosal Impedance
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 33
- Enrollment target
NCT03152279: Completed study, sponsored by Vanderbilt University Medical Center.
NCT03152279 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03152279 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
Study Summary
Increased intestinal permeability can represent compromise of the epithelium's integrity and is thought to be the primary mechanism in patients who develop Celiac Disease (CeD) and non-celiac gluten sensitivity when gluten peptides cross the barrier and trigger an immune response. In this study, the investigators propose to use a novel, minimally invasive technology to detect mucosal damage (i.e. barrier dysfunction) in the duodenal epithelium. The primary aim of this study is to identify if there is a difference in duodenal mucosal impedance between CeD and control patients.
Primary Outcome
Identify if there is a difference in duodenal mucosal impedance between CeD and control patients
Interventions
- DIAGNOSTIC_TEST Blood sample
- DIAGNOSTIC_TEST Mucosal Impedance Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2016-12 |
| Est. Completion | 2018-11-14 |
What the finished NCT03152279 record still lists
NCT03152279 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Blood sample is the first listed.
NCT03152279 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03152279 about?
NCT03152279 is a clinical study titled "Assessment of Duodenal Epithelial Integrity in Celiac Disease With Mucosal Impedance". Increased intestinal permeability can represent compromise of the epithelium's integrity and is thought to be the primary mechanism in patients who develop Celiac Disease (CeD) and non-celiac gluten sensitivity when gluten peptides cross the barrier and trigger an immune response. In this study, the...
What is the current status of trial NCT03152279?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2016-12. Estimated completion is 2018-11-14.
What interventions are being tested in trial NCT03152279?
The interventions under investigation include: Blood sample (DIAGNOSTIC_TEST), Mucosal Impedance Catheter (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03152279?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia